title: Before influenza tests results are available, can droplet precautions be instituted if influenza is suggested by leukopenia, relative lymphopenia, or thrombocytopenia?
authors.forename: Jean E
authors.initials: JE
authors.lastname: Hage
authors.forename: Andrew
authors.initials: A
authors.lastname: Petelin
authors.forename: Burke A
authors.initials: BA
authors.lastname: Cunha
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification / Q000472:pathogenicity; D053122:Influenza A Virus, H3N2 Subtype / Q000302:isolation & purification / Q000472:pathogenicity; D007251:Influenza, Human / Q000150:complications / Q000175:diagnosis*; D007958:Leukocyte Count / Q000379:methods*; D008231:Lymphopenia / Q000209:etiology / Q000473:pathology*; D013921:Thrombocytopenia / Q000209:etiology / Q000473:pathology*
chemical_list: D015415:Biomarkers